Trio Exome Analysis of Family Pedigree | Actia | MedGenome

What is a Trio Exome Analysis?

Next generation sequencing of trio family pedigrees offers a powerful approach for the identification of causal mutations for inherited diseases. Trio analysis can be used to identify variants inherited from the parents causing recessive disease or dominant disease. In case of recessive disease, the offspring inherits two defective copies of the gene, one from each parent resulting in the clinical condition. In case of dominant disease, the defective copy of gene is inherited by the offspring from the similarly affected parent. Additionally de novo variants that occur in the offspring but are not present in either of the parents can also be detected.

Trio analysis using either Whole exome or Clinical exome sequencing facilitates analyses of thousands of genes simultaneously to identify genetic alterations like insertions/deletions (indels), single nucleotide variants (SNVs) and copy number variations (CNVs). This comprehensive analysis reduces false positive calls and enables the prioritisation of potential disease causing variants. There is 5-10% increase compared to analyzing proband only.

When do you need to get tested?

When the individuals’ clinical examination, laboratory findings and family history suggests underlying genetic etiology:

  • To confirm the genetic diagnosis
  • To facilitate medical intervention and treatment
  • To guide reproductive planning and assessment of recurrence risk
  • To determine the molecular basis of genetically heterogeneous diseases
  • To determine the etiology of undiagnosed rare diseases to end the diagnostic odyssey
  • To facilitate prognosis

What are the advantages of MedGenome’s Trio Exome Test?

  • Mendelian QC to assess the relatedness based on variants obtained
  • Combined variant calling increases the accuracy of variant calling and ability to make variant calls in low coverage regions
  • Better diagnostic yield compared to analyzing single proband sample
  • Simultaneous analysis for all modes of inheritance i.e. autosomal recessive, autosomal dominant, and de novo variants
  • Prioritization of variants based on patient phenotype
  • Ability to ascertain the significance of clinically relevant variants especially compound heterozygous and de novo variants

Note: Triplet repeat expansions, translocations cannot be detected by this methodology. Genetic changes present outside of the targetted region will not be detected.

What is the test methodology?

Next-generation Sequencing Using genomic DNA extracted from blood, the coding regions of all the genes are captured and sequenced simultaneously by NGS technology on an Illumina platform. The sequence data that is generated is aligned and analyzed for sequence variants.

Test sample requirements

Blood (3-5ml in EDTA tubes)

Required forms
  • Relevant clinical information including all the clinical presentations and symptoms
  • Test request form
Turn around time (TAT)

21 Working Days for NGS

Extracted DNA samples (1µg high-quality DNA)

FREE GENETIC COUNSELLING

Actia offers all your patients FREE pre and post-test genetic
counselling with our expert and certified genetic counsellors. We provide the best available
support for your patients and families with:

  • Helpful customer service
  • Clear interpretation of results
  • Counselling sessions with our Genetic Counsellors

Brochures

Trio Exome Analysis

Blog

Spina bifida is part of a group of birth defects called neural tube defects.

Patient Stories

Genetic testing provides hope for couple with family history of hearing loss

Talk to our Genetic experts for free today or reach out to us

Our certified genetic specialists are available to discuss your queries

Test Menu

Genetic Counselling

Microsites

Collaterals

Contact Us